The Right TraderBeta

Marker Therapeutics, Inc.

MRKR
—
Advanced chart & tools →
Marker Therapeutics, Inc.MRKR
$0.00
+$0.00(+NaN%)Past Year
$0.00$0.00$0.00$0.00
Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap
—
P/E ratio
—
EPS (diluted)
$-0.79
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$3.55M
Net income
$-12.16M
Net margin
-343.0%
Gross margin
—

Dividends & financials

Marker Therapeutics, Inc. (MRKR) reported revenue of $3.55M and net income of $-12.16M, or $-0.79 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.